Clinical Trial

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

Study Description

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

The purpose of this study is to assess whether withdrawal of aminosalicylate (5-ASA) is non-inferior to continuation of 5-ASA therapy in Crohn's disease (CD) subjects in remission.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

5-ASA Withdrawal

Withdrawal of 5-ASA therapy

Additional Information

Official Study Title

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease (STATIC) Study: A Randomized, Open-label, Non-inferiority Trial

Clinical Trial ID

NCT03261206

ParticipAid ID

nel4le